Status:

COMPLETED

Short-term Memory Assessment in Patients With Poststroke Aphasia

Lead Sponsor:

University Hospital, Ghent

Conditions:

Aphasia, Acquired

Short-Term Memory Impairment

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

Background and aim There is a growing awareness that people with aphasia (language problems) after a stroke often have difficulties with their short-term memory (STM). As a result, the explanation un...

Detailed Description

1. Introduction 1.1. Background The literature has witnessed a steady increase in the number of studies investigating the role of short-term memory (STM) and working memory (WM) impairments in...

Eligibility Criteria

Inclusion

  • Inclusion Criteria aphasia patients:
  • Aphasia after an initial ischemic or hemorrhagic stroke diagnosed by the speech pathologist and a screening instrument to evaluate aphasia (ScreeLing)
  • Age 18-85 years
  • Speak Dutch as a mother language
  • Acute to subacute phase poststroke
  • Imaging (CT/MRI) is available prior to inclusion
  • Signed informed consent
  • Exclusion Criteria aphasia patients:
  • There is a history of other diseases of the central nervous system causing non-stroke related speech-, language or cognitive disorder
  • They present severe sensory impairment or other co-morbidities prohibiting administration of the assessment tool
  • Excessive active alcohol or drug abuse
  • Transient ischemic attack (i.e., TIA)
  • Inclusion Criteria healthy participants:
  • Normal score (\> 26) on the Montreal Cognitive Assessment (MOCA)
  • Speak Dutch as a mother language
  • Exclusion Criteria aphasia patients:
  • Have no history of stroke or other central nervous system diseases that affect speech, language or cognition
  • Have no severe auditory or visual disorders

Exclusion

    Key Trial Info

    Start Date :

    April 30 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    April 30 2023

    Estimated Enrollment :

    9 Patients enrolled

    Trial Details

    Trial ID

    NCT06068296

    Start Date

    April 30 2023

    End Date

    April 30 2023

    Last Update

    October 5 2023

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Ghent University Hospital

    Ghent, East Flanders, Belgium, 9000

    2

    University Hospital Ghent

    Ghent, Belgium, 9000